Marqeta Valuation
Is 8QJ undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 8QJ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate 8QJ's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate 8QJ's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 8QJ?
Key metric: As 8QJ is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is 8QJ's PE Ratio? | |
|---|---|
| PE Ratio | 145x |
| Earnings | US$14.03m |
| Market Cap | US$2.03b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.9x |
| Enterprise Value/EBITDA | -32.6x |
| PEG Ratio | -4.3x |
Price to Earnings Ratio vs Peers
How does 8QJ's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 19.9x | ||
HYQ Hypoport | 46.2x | 30.4% | €1.4b |
GLJ Grenke | 9.8x | 25.2% | €731.6m |
FTK flatexDEGIRO | 12.4x | 8.5% | €1.5b |
PBB Deutsche Pfandbriefbank | 11.2x | 35.3% | €691.9m |
8QJ Marqeta | 145x | -33.8% | €2.0b |
Price-To-Earnings vs Peers: 8QJ is expensive based on its Price-To-Earnings Ratio (145x) compared to the peer average (20x).
Price to Earnings Ratio vs Industry
How does 8QJ's PE Ratio compare vs other companies in the European Diversified Financial Industry?
| 7 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 7 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: 8QJ is expensive based on its Price-To-Earnings Ratio (145x) compared to the European Diversified Financial industry average (10.7x).
Price to Earnings Ratio vs Fair Ratio
What is 8QJ's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 145x |
| Fair PE Ratio | 8.3x |
Price-To-Earnings vs Fair Ratio: 8QJ is expensive based on its Price-To-Earnings Ratio (145x) compared to the estimated Fair Price-To-Earnings Ratio (8.3x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €3.84 | €5.09 +32.6% | 16.1% | €6.59 | €3.77 | n/a | 15 |
| Nov ’25 | €5.25 | €6.62 +26.1% | 13.8% | €8.25 | €5.04 | n/a | 17 |
| Oct ’25 | €4.34 | €6.64 +53.0% | 13.2% | €8.24 | €5.50 | n/a | 17 |
| Sep ’25 | €4.78 | €6.64 +38.9% | 13.2% | €8.24 | €5.50 | n/a | 17 |
| Aug ’25 | €4.94 | €6.76 +36.7% | 13.5% | €8.25 | €5.04 | n/a | 17 |
| Jul ’25 | €4.98 | €6.97 +40.0% | 12.6% | €8.38 | €5.12 | n/a | 17 |
| Jun ’25 | €4.90 | €6.92 +41.2% | 11.8% | €8.29 | €5.52 | n/a | 17 |
| May ’25 | €5.00 | €7.14 +42.8% | 11.4% | €8.45 | €5.63 | n/a | 17 |
| Apr ’25 | €5.50 | €7.08 +28.7% | 11.6% | €8.30 | €5.54 | n/a | 16 |
| Mar ’25 | €5.90 | €7.17 +21.5% | 13.0% | €9.25 | €5.55 | n/a | 17 |
| Feb ’25 | €5.50 | €6.78 +23.2% | 15.9% | €8.28 | €4.60 | n/a | 17 |
| Jan ’25 | €6.40 | €6.59 +3.0% | 16.5% | €8.26 | €4.59 | n/a | 17 |
| Dec ’24 | €5.75 | €6.47 +12.5% | 18.7% | €8.28 | €4.14 | n/a | 19 |
| Nov ’24 | €4.84 | €6.32 +30.5% | 19.0% | €8.48 | €3.77 | €5.25 | 18 |
| Oct ’24 | €5.60 | €6.27 +12.0% | 19.8% | €8.43 | €3.75 | €4.34 | 16 |
| Sep ’24 | €5.60 | €6.24 +11.5% | 18.6% | €8.33 | €3.70 | €4.78 | 18 |
| Aug ’24 | €5.05 | €5.87 +16.2% | 23.6% | €9.14 | €4.11 | €4.94 | 17 |
| Jul ’24 | €4.32 | €5.87 +35.9% | 23.6% | €9.14 | €4.11 | €4.98 | 17 |
| Jun ’24 | €4.40 | €5.97 +35.7% | 23.6% | €9.29 | €4.18 | €4.90 | 17 |
| May ’24 | n/a | €6.22 0% | 24.0% | €9.08 | €4.08 | €5.00 | 17 |
| Apr ’24 | n/a | €6.56 0% | 20.4% | €9.22 | €5.07 | €5.50 | 17 |
| Mar ’24 | n/a | €7.23 0% | 25.6% | €12.19 | €4.69 | €5.90 | 18 |
| Feb ’24 | n/a | €8.57 0% | 25.7% | €12.74 | €5.92 | €5.50 | 18 |
| Jan ’24 | n/a | €9.14 0% | 24.2% | €13.21 | €6.60 | €6.40 | 18 |
| Dec ’23 | n/a | €9.54 0% | 23.8% | €13.55 | €6.77 | €5.75 | 18 |
| Nov ’23 | n/a | €11.37 0% | 21.5% | €15.34 | €7.16 | €4.84 | 17 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.
Discover undervalued companies
Yeahka
HK$4.2b
An investment holding company, provides payment and business services to merchants and consumers in the People’s Republic of China.
4YE
HK$1.19
7D
-4.8%
1Y
-30.0%
ORIX
JP¥3.8t
Provides diversified financial services in Japan, the United States, Asia, Europe, Australasia, and the Middle East.
OIX
JP¥20.20
7D
0%
1Y
21.0%
Exor
€20.5b
Engages in the luxury goods, automotive, agricultural and construction equipment, commercial vehicles, and professional football businesses worldwide.
EYX
€94.45
7D
1.7%
1Y
7.6%